Okaba Ebikonbowei
University of Africa, Toru Orua, Bayelsa State, Nigeria.
Niger Med J. 2024 Sep 26;65(4):512-523. doi: 10.60787/nmj-v65i3-492. eCollection 2024 Jul-Aug.
Nigeria has one of the highest rates of cervical cancer morbidity and mortality in Sub-Saharan Africa. Both the human papillomavirus vaccine (HPV) and cervical screening are effective prevention strategies against both HPV infection and cervical cancer. Lack of awareness, limited knowledge, limited decision-making agency, lack of spousal support and stigma are barriers to uptake of these preventive measures. Cervical cancer is the second most diagnosed cancer and the third leading cause of cancer death in women worldwide. Eighty three percent (83%) of the world's new cases and 85% of all cervical cancer-related deaths occur in developing countries. It is primarily caused by human papilloma virus (HPV); a sexually transmitted pathogen that could be prevented with safe sexual practice and using vaccines, among others. The aim of the study was to assess the knowledge and attitude of reproductive age group women in low resource setting in towards cervical cancer and its prevention in Yenagoa, Bayelsa State Nigeria.
This study employed the use of a descriptive study design to examine the knowledge and assessment of cervical cancer among women of reproductive age (19-54), about cervical cancer, its prevention, and their utilization of Pap smear screening; using a convenience sample of 406 women in two communities (Okaka and Agudama) in Yenagoa Local Government Area of Bayelsa State, Nigeria. Women voluntarily completed a structured questionnaire.
Results showed that women who participated in the study were aware of cervical cancer (78.3%; n=318) but many (70.4%; n= 286) were unaware of Pap smears as the screening tests for cervical cancer. Although few of them (45.6%; n =185) knew about a screening center, out of which 17.6% (n= 32) reported that the screening center was less than 2km away from their residences.
There is need for health care professionals, to intensify efforts to increase awareness about cervical cancer screening and encourage women through the different clinics to use these services. The benefits of screening and early diagnosis of cervical cancer should be emphasized to enhance the utilization of cervical cancer screening services.
在撒哈拉以南非洲地区,尼日利亚的宫颈癌发病率和死亡率位居前列。人乳头瘤病毒疫苗(HPV)接种和宫颈癌筛查都是预防HPV感染和宫颈癌的有效策略。意识缺乏、知识有限、决策自主权受限、配偶支持不足以及污名化是采取这些预防措施的障碍。宫颈癌是全球女性中第二大最常被诊断出的癌症,也是癌症死亡的第三大主要原因。全球83%的新发病例和85%的宫颈癌相关死亡发生在发展中国家。宫颈癌主要由人乳头瘤病毒(HPV)引起,这是一种性传播病原体,可通过安全性行为和接种疫苗等方式预防。本研究的目的是评估尼日利亚巴耶尔萨州耶那戈阿资源匮乏地区育龄妇女对宫颈癌及其预防的知识和态度。
本研究采用描述性研究设计,以尼日利亚巴耶尔萨州耶那戈阿地方政府辖区两个社区(奥卡卡和阿古达马)的406名妇女为便利样本,调查育龄(19 - 54岁)妇女对宫颈癌、其预防措施以及巴氏涂片筛查利用情况的知识和评估。妇女们自愿填写一份结构化问卷。
结果显示,参与研究的妇女知晓宫颈癌(78.3%;n = 318),但许多人(70.4%;n = 286)不知道巴氏涂片是宫颈癌的筛查检测方法。虽然她们中少数人(45.6%;n = 185)知道有一个筛查中心,其中17.6%(n = 32)报告称筛查中心距离她们的住所不到2公里。
医疗保健专业人员需要加大力度,提高对宫颈癌筛查的认识,并通过不同诊所鼓励妇女使用这些服务。应强调宫颈癌筛查和早期诊断的益处,以提高宫颈癌筛查服务的利用率。